Results 1-20 of 285 for hpv speaker:Simon Harris

Ceisteanna ó Cheannairí - Leaders' Questions (17 Apr 2024)

Simon Harris: ...improvement than the European average of just 10% and 5%, respectively. We have a plan to eradicate cervical cancer. Huge progress has been made and I note the Deputy's support in that regard for the HPV vaccine and the like. We can actually eradicate a cancer in this country by 2040, and the Minister for Health will publish the plan as to how he intends to do that this year. I accept...

Science Week 2021: Statements (10 Nov 2021)

Simon Harris: ...debate in a collaborative fashion, but all too often we see pseudoscience on the floor of this House. I remember clearly during my time as Minister for Health, the misinformation, disinformation and the downright whatever on the HPV vaccine. We know where the science has brought us on that. This is a vaccine that can stop women getting cancer. It can save their lives. We all know,...

Emergency Bed Capacity: Statements (24 Jun 2020)

Simon Harris: ...to inform the Deputy that a restart plan was published today. CervicalCheck will recommence on a phased basis next month, with letters going out from 6 July to some 15,000 women a week, and a new HPV programme will commence. In regard to critical care, the temporary capacity to which the Deputy referred effectively needs to be made permanent. We need to take the opportunity now to...

Emergency Bed Capacity: Statements (24 Jun 2020)

Simon Harris: ...., and these will be clinical decisions made in the programme. I welcome the fact that from 6 July, screening letters will start going out from CervicalCheck. The Deputy pushed for switching to a HPV test as well and there will be an information awareness campaign about these processes. I spoke to Dr. Colm Henry about that today. With regard to the Deputy's question on winter...

Covid-19 (Health): Statements (4 Jun 2020)

Simon Harris: ...leading these programmes are working incredibly hard. I was left in absolutely no doubt of that. They are not just waiting. To give an example, already CervicalCheck has carried out trials of the new HPV test. It invited women to come forward through both the Irish Family Planning Association and the Well Woman Centre to see how our new HPV test is working. BreastCheck is currently...

Written Answers — Department of Health: Vaccination Programme (5 Mar 2020)

Simon Harris: ...any impact that their data may have on the overall assessment of the benefits and risks of a medicinal product. Taking into account the totality of the available information, the benefits of the HPV vaccines continue to outweigh their risks. The safety of these vaccines continues to be monitored at EU level through the EMA and its expert committees, which includes representatives from...

Written Answers — Department of Health: Medicinal Products (5 Mar 2020)

Simon Harris: ...(including vaccines) is entirely without risk, the safety profile of Gardasil, as with all medicines, is carefully monitored and any new evidence concerning side-effects is taken into account. HPV vaccine is one of the most closely studied and monitored medicinal products around. The HPRA and the European Medicines Agency (EMA) continually monitor adverse events to vaccination. The...

Written Answers — Department of Health: Vaccination Programme (17 Dec 2019)

Simon Harris: ...introduction of new vaccines in Ireland and to keep abreast of changes in the patterns of disease.  Therefore, the immunisation schedule will continue to be amended over time. In 2009 the NIAC recommended HPV (human papillomavirus) vaccination for all 12-13 year old girls to reduce their risk of developing cervical cancer when they are adults.  In September 2010 the HPV...

Written Answers — Department of Health: Vaccination Programme (17 Dec 2019)

Simon Harris: ...the introduction of new vaccines in Ireland and to keep abreast of changes in the patterns of disease.  Therefore, the immunisation schedule will continue to be amended over time. A gender neutral HPV vaccination programme which targets all girls and boys in first year of secondary school was introduced in September 2019.   The ages at which vaccines are...

Written Answers — Department of Health: Vaccination Programme (17 Dec 2019)

Simon Harris: The Health Products Regulatory Authority (HPRA) is responsible for monitoring the safety and quality of all medicines including vaccines that are licensed in Ireland.  All HPV vaccines available in the EU are authorised by the European Medicines Agency (EMA).  Gardasil vaccines were first authorised by the European Commission in 2006 to be placed on the market for use across the...

Joint Oireachtas Committee on Health: Quarterly Meeting on Health Issues (11 Dec 2019)

Simon Harris: ...at this committee on many occasions, has stabilised. I thank the staff of CervicalCheck and the HSE for their incredible work in this regard. Implementation of Dr. Scally's recommendations is well under way. In the first quarter of 2020, which is only weeks away, we will move to HPV primary screening, becoming one of the first countries in the world to do so. I have written to the HSE...

Joint Oireachtas Committee on Health: Quarterly Meeting on Health Issues (11 Dec 2019)

Simon Harris: ...I had meetings with the social media companies recently. Social media has been a really great tool but would Brexit have happened, would Donald Trump have been elected, and would the uptake rate relating to the HPV vaccine have dropped so significantly if we did not have social media? Who knows. We certainly know that the spread of disinformation and misinformation on social media has...

Written Answers — Department of Health: HSE Funding (10 Dec 2019)

Simon Harris: ...& Disability Need Assessments 14.5 13.2 Palliative Care - Marymount & St Francis Hospice 2 2 National Screening Service (Cervical Check incl. HPV vaccine) 9 8.4 Termination of Pregnancy 12 12 Primary Care Scheme Changes 70.3 ...

Written Answers — Department of Health: Cancer Screening Programmes (10 Dec 2019)

Simon Harris: ...do all we can, therefore, to make cervical cancer a rare disease in Ireland. This can be done through a combination of screening and vaccination, together with strong uptake, and this is my priority. HPV vaccination has now been extended to boys as well as girls, and the HSE has committed to introducing HPV primary screening in Q1 next year. The Report of the Expert Panel contains ten...

Written Answers — Department of Health: Cancer Screening Programmes (10 Dec 2019)

Simon Harris: Funding to implement the switch to HPV screening was allocated in Budget 2019. The introduction of primary HPV screening is in line with developments in cervical screening internationally. Ireland will be among the first countries in the world to make this transition. The HSE has been engaging with other countries who have already made the switch – the Netherlands, and Australia - or...

Written Answers — Department of Health: Cancer Screening Programmes (10 Dec 2019)

Simon Harris: ...in regard to colposcopy services, and I have written to the HSE to request that it take full account of these recommendations in the detailed work underway to prepare for the introduction of HPV primary screening, including colposcopy capacity planning.

Ceisteanna Eile - Other Questions: Cancer Screening Programmes (26 Nov 2019)

Simon Harris: ..., of whether we can do more in Ireland or repatriate our service, it is our intention to significantly expand those services and create a national screening laboratory in the Coombe. The move to HPV testing, as well as reducing the number of false negatives and positives, will provide an opportunity to do more here in Ireland.

Written Answers — Department of Health: Vaccination Programme (26 Nov 2019)

Simon Harris: ...for vaccine trials. The Health Products Regulatory Authority (HPRA) is responsible for monitoring the safety and quality of all medicines including vaccines that are licensed in Ireland. All HPV vaccines available in the EU are authorised by the European Medicines Agency (EMA). The HPRA has advised that the specific HPV vaccine trial has not been identified in this query....

Written Answers — Department of Health: Vaccination Programme (19 Nov 2019)

Simon Harris: ...of new vaccines in Ireland and to keep abreast of changes in the patterns of disease. Therefore, the immunisation schedule will continue to be amended over time. In 2009 the NIAC recommended HPV (human papillomavirus) vaccination for all 12-13 year old girls to reduce their risk of developing cervical cancer when they are adults. In September 2010 the HPV vaccination programme was...

Written Answers — Department of Health: Health Services Provision (14 Nov 2019)

Simon Harris: ...Immunisation Office has provided vaccine stock to the sexual health programme based on forecasted quantities. All vaccine purchases must be forecasted 6-9 months in advance. The NIO purchased HPV4 vaccine on behalf of the sexual health programme prior to HPV9 being available. Only sufficient stock of HPV9 for the national universal first year of second level schools programme was...